Literature DB >> 856674

Plasma levels and intestinal absorption of 25-hydroxyvitamin D in patients with small bowel resection.

J E Compston, B Creamer.   

Abstract

Plasma levels of 25-hydroxyvitamin D (25-OHD) were found to be significantly reduced in a group of patients with small bowel resection when compared with normal controls. Plasma levels of 25-OHD after an oral dose of 25-hydroxyvitamin D3 (25-ohd3) were also reduced in the patient group. Dietary intake of vitamin D tended to be low in many patients, but seasonal variation of plasma 25-OHD levels indicated normal exposure to sunlight in most of the patients studied. It is suggested that these studies provide some evidence for malabsorption of 25-OHD after small bowel resection, which, it is postulated, may be due to interruption of the enterohepatic circulation of bile acids and of 25-OHD. These factors may contribute towards the low plasma levels of 25-OHD found in the patient group.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 856674      PMCID: PMC1411385          DOI: 10.1136/gut.18.3.171

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  11 in total

1.  METABOLISM OF VITAMIN D. I. PREPARATION OF RADIOACTIVE VITAMIN D AND ITS INTESTINAL ABSORPTION IN THE RAT.

Authors:  D SCHACHTER; J D FINKELSTEIN; S KOWARSKI
Journal:  J Clin Invest       Date:  1964-05       Impact factor: 14.808

2.  Competitive protein-binding assay for 25-hydroxycholecalciferol.

Authors:  S Edelstein; M Charman; D E Lawson; E Kodicek
Journal:  Clin Sci Mol Med       Date:  1974-02

3.  Competitive protein-binding radioassay for 25-hydroxycholecalciferol.

Authors:  J G Haddad; K J Chyu
Journal:  J Clin Endocrinol Metab       Date:  1971-12       Impact factor: 5.958

4.  Seasonal variations in serum 25-hydroxycholecalciferol in healthy people.

Authors:  M McLaughlin; P R Raggatt; A Fairney; D J Brown; E Lester; M R Wills
Journal:  Lancet       Date:  1974-03-30       Impact factor: 79.321

5.  Intestinal absorption of 25-hydroxycholecalciferol.

Authors:  T C Stamp
Journal:  Lancet       Date:  1974-07-20       Impact factor: 79.321

6.  Intestinal absorption and esterification of vitamin D3-1,2-3H in man.

Authors:  R Blomstrand; L Forsgren
Journal:  Acta Chem Scand       Date:  1967

7.  Absorption of vitamin D3-3H in control subjects and patients with intestinal malabsorption.

Authors:  G R Thompson; B Lewis; C C Booth
Journal:  J Clin Invest       Date:  1966-01       Impact factor: 14.808

8.  Seasonal changes in human plasma levels of 25-hydroxyvitamin D.

Authors:  T C Stamp; J M Round
Journal:  Nature       Date:  1974-02-22       Impact factor: 49.962

9.  Metabolism of vitamin D3-3H in human subjects: distribution in blood, bile, feces, and urine.

Authors:  L V Avioli; S W Lee; J E McDonald; J Lund; H F DeLuca
Journal:  J Clin Invest       Date:  1967-06       Impact factor: 14.808

10.  "Activation" of vitamin D by the liver.

Authors:  G Ponchon; A L Kennan; H F DeLuca
Journal:  J Clin Invest       Date:  1969-11       Impact factor: 14.808

View more
  25 in total

Review 1.  The clinical use of vitamin D metabolites and their potential developments: a position statement from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) and the International Osteoporosis Foundation (IOF).

Authors:  Luisella Cianferotti; Claudio Cricelli; John A Kanis; Ranuccio Nuti; Jean-Y Reginster; Johann D Ringe; Rene Rizzoli; Maria Luisa Brandi
Journal:  Endocrine       Date:  2015-05-01       Impact factor: 3.633

2.  Increased rate of spinal trabecular bone loss in patients with inflammatory bowel disease.

Authors:  R J Motley; E O Crawley; C Evans; J Rhodes; J E Compston
Journal:  Gut       Date:  1988-10       Impact factor: 23.059

Review 3.  Nutritional disturbances in Crohn's disease.

Authors:  A D Harries; R V Heatley
Journal:  Postgrad Med J       Date:  1983-11       Impact factor: 2.401

4.  Faecal tritium excretion after intravenous administration of 3H-25-hydroxyvitamin D3 in control subjects and in patients with malabsorption.

Authors:  J E Compston; A L Merrett; J E Ledger; B Creamer
Journal:  Gut       Date:  1982-04       Impact factor: 23.059

5.  Reduced bone formation in patients with osteoporosis associated with inflammatory bowel disease.

Authors:  P I Croucher; S Vedi; R J Motley; N J Garrahan; M R Stanton; J E Compston
Journal:  Osteoporos Int       Date:  1993-09       Impact factor: 4.507

6.  Comparative absorption of vitamin D3 and 25-hydroxyvitamin D3 in intestinal disease.

Authors:  M Davies; E B Mawer; E L Krawitt
Journal:  Gut       Date:  1980-04       Impact factor: 23.059

7.  Changes in plasma half-life and clearance of 3H-25-hydroxyvitamin D3 in patients with intestinal malabsorption.

Authors:  A J Batchelor; G Watson; J E Compston
Journal:  Gut       Date:  1982-12       Impact factor: 23.059

8.  Vitamin D status and measurements of markers of bone metabolism in patients with small intestinal resection.

Authors:  K V Haderslev; P B Jeppesen; H A Sorensen; P B Mortensen; M Staun
Journal:  Gut       Date:  2003-05       Impact factor: 23.059

9.  Vitamin D status in Crohn's disease: association with nutrition and disease activity.

Authors:  A D Harries; R Brown; R V Heatley; L A Williams; S Woodhead; J Rhodes
Journal:  Gut       Date:  1985-11       Impact factor: 23.059

10.  Osteoporosis in patients with inflammatory bowel disease.

Authors:  J E Compston; D Judd; E O Crawley; W D Evans; C Evans; H A Church; E M Reid; J Rhodes
Journal:  Gut       Date:  1987-04       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.